|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.2370 - 0.2500|
|52 Week Range||0.2000 - 1.2732|
|Beta (5Y Monthly)||0.95|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Jason Fung, and Benjamin Bikman, Ph. join StageZero Life Sciences' Scientific Advisory Board to advance the Company's mission of improving cancer and other chronic disease outcomes through early detection and interventionTORONTO, ON and RICHMOND, VA / ACCESSWIRE / December 14, 2021 /StageZero Life Sciences, Ltd.
Teams up with OK2Roam and VFS Global to streamline COVID-19 testing protocols for travelers from Canada and the U.TORONTO, ON and RICHMOND, VA / ACCESSWIRE / December 13, 2021 /StageZero Life Sciences, Ltd.
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / December 10, 2021 /StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced that it has engaged Richmond Hill based SRCO Professional Corporation ("SRCO") as its auditors.